The association between the presence of FOXP3+ T lymphocytes and survival of CRC patients was extracted from fourteen studies (Fig. 5) stratified by tumor location, with eleven evaluating the CC, four the TS, and three the IM. The gene discussed is FOXP3; the disease is neoplasm.